Prescription drug · ANDA
Telmisartan and Amlodipine NDC 68180-197
Telmisartan 40 mg/1; Amlodipine besylate 10 mg/1 · Tablet · Oral · Lupin Pharmaceuticals, Inc.
NDC codes
FDA NDC DirectoryProduct information
- Brand name (proprietary)
- Telmisartan and Amlodipine
- Generic name (nonproprietary)
- telmisartan and amlodipine
- Active ingredients
- Telmisartan — 40 mg/1Amlodipine besylate — 10 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Lupin Pharmaceuticals, Inc.NDC labeler code 68180
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 201586
- Marketing start
- Listing expires
- Other FDA classes
- Angiotensin 2 Receptor Antagonists (Mechanism)Calcium Channel Antagonists (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)Dihydropyridines (Chemical structure)
- Identifiers
- Product ID 68180-197_17a6182b-5050-470e-aa1d-1605fa9e088eSPL ID 17a6182b-5050-470e-aa1d-1605fa9e088eSPL set ID a97fefa6-99e6-4eb7-9393-ab2252a2c7d8RxCUI 876514, 876519, 876524, 876529UNII U5SYW473RQ, 864V2Q084HUPC 0368180196068
- Pharmacologic class
- Angiotensin 2 Receptor Blocker; Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Telmisartan and amlodipine tablet is an angiotensin II receptor blocker (ARB) and a dihydropyridine calcium channel blocker (DHP-CCB) combination product indicated for the treatment of hypertension alone or with other antihypertensive agents to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1 ) Telmisartan and amlodipine tablets are indicated as initial therapy in patients likely to need multiple antihypertensive agents to achieve their blood pressure goals ( 1 ) Telmisartan and amlodipine tablets are indicated for the treatment of hypertension, alone or with other antihypertensive ag…
Excerpt only. Read the full label for complete information.
About NDC 68180-197
- What is NDC 68180-197?
- 68180-197 is the product NDC for Telmisartan and Amlodipine, Telmisartan 40 mg/1; Amlodipine besylate 10 mg/1 tablet, listed with the FDA by Lupin Pharmaceuticals, Inc..
- What drug is associated with this NDC?
- Telmisartan and Amlodipine.
- What is the active ingredient?
- Telmisartan, Amlodipine besylate.
- Who is the labeler?
- Lupin Pharmaceuticals, Inc., NDC labeler code 68180. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Telmisartan and Amlodipine?
- 9 other product NDCs are listed under this name. See all Telmisartan and Amlodipine NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Telmisartan and Amlodipine products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Telmisartan and Amlodipine | Telmisartan 40 mg/1; Amlodipine besylate 5 mg/1 | TabletOral | Alembic Pharmaceuticals Limited | 46708-184 | 46708-0184-08 |
| Telmisartan and Amlodipine | Telmisartan 40 mg/1; Amlodipine besylate 10 mg/1 | TabletOral | Alembic Pharmaceuticals Limited | 46708-185 | 46708-0185-08 |
| Telmisartan and Amlodipine | Telmisartan 80 mg/1; Amlodipine besylate 5 mg/1 | TabletOral | Alembic Pharmaceuticals Limited | 46708-186 | 46708-0186-06 |
| Telmisartan and Amlodipine | Telmisartan 80 mg/1; Amlodipine besylate 10 mg/1 | TabletOral | Alembic Pharmaceuticals Limited | 46708-187 | 46708-0187-06 |
| Telmisartan and Amlodipine | Telmisartan 40 mg/1; Amlodipine besylate 5 mg/1 | TabletOral | Mylan Pharmaceuticals Inc. | 0378-1075 | 00378-1075-93 |
| Telmisartan and Amlodipine | Telmisartan 40 mg/1; Amlodipine besylate 10 mg/1 | TabletOral | Mylan Pharmaceuticals Inc. | 0378-1076 | 00378-1076-93 |
| Telmisartan and Amlodipine | Telmisartan 80 mg/1; Amlodipine besylate 5 mg/1 | TabletOral | Mylan Pharmaceuticals Inc. | 0378-1077 | 00378-1077-93 |
| Telmisartan and Amlodipine | Telmisartan 80 mg/1; Amlodipine besylate 10 mg/1 | TabletOral | Mylan Pharmaceuticals Inc. | 0378-1078 | 00378-1078-93 |
| Telmisartan and Amlodipine | Telmisartan 40 mg/1; Amlodipine besylate 5 mg/1 | TabletOral | Lupin Pharmaceuticals, Inc. | 68180-196 | — |
Other NDCs under ANDA 201586
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Telmisartan and Amlodipine | Telmisartan 40 mg/1; Amlodipine besylate 5 mg/1 | TabletOral | Lupin Pharmaceuticals, Inc. | 68180-196 |